Nu Skin Enterprises Inc. (NYSE:NUS) had its target price lifted by equities researchers at Jefferies Group from $53.00 to $61.00 in a note issued to investors on Thursday. The brokerage currently has a “hold” rating on the stock. Jefferies Group’s price objective suggests a potential downside of 2.06% from the company’s previous close.

Other analysts also recently issued research reports about the stock. Citigroup Inc. increased their target price on shares of Nu Skin Enterprises from $66.00 to $69.00 and gave the stock a “buy” rating in a research report on Wednesday. Pivotal Research increased their target price on shares of Nu Skin Enterprises from $60.00 to $70.00 and gave the stock a “buy” rating in a research report on Friday, August 5th. Deutsche Bank AG increased their target price on shares of Nu Skin Enterprises from $55.00 to $57.00 and gave the stock a “buy” rating in a research report on Friday, August 5th. Zacks Investment Research raised shares of Nu Skin Enterprises from a “hold” rating to a “strong-buy” rating and set a $52.00 target price for the company in a research report on Tuesday, June 21st. Finally, Stifel Nicolaus increased their target price on shares of Nu Skin Enterprises from $34.00 to $45.00 and gave the stock a “sell” rating in a research report on Friday, August 5th. Two research analysts have rated the stock with a sell rating, four have given a hold rating, four have issued a buy rating and one has assigned a strong buy rating to the company’s stock. Nu Skin Enterprises presently has an average rating of “Hold” and an average target price of $50.72.

Analyst Recommendations for Nu Skin Enterprises (NYSE:NUS)

Nu Skin Enterprises (NYSE:NUS) traded up 1.97% during mid-day trading on Thursday, reaching $63.51. 153,954 shares of the company’s stock were exchanged. The company’s 50 day moving average price is $58.46 and its 200-day moving average price is $45.95. Nu Skin Enterprises has a 52 week low of $23.51 and a 52 week high of $63.82. The company has a market capitalization of $3.55 billion, a P/E ratio of 36.44 and a beta of 1.75.

Nu Skin Enterprises (NYSE:NUS) last posted its quarterly earnings data on Thursday, August 4th. The company reported $0.79 EPS for the quarter, beating the Zacks’ consensus estimate of $0.78 by $0.01. Nu Skin Enterprises had a net margin of 4.52% and a return on equity of 18.46%. The company earned $600.05 million during the quarter, compared to the consensus estimate of $578.87 million. During the same quarter in the prior year, the company posted $0.75 EPS. The company’s quarterly revenue was up 7.2% compared to the same quarter last year. On average, equities research analysts expect that Nu Skin Enterprises will post $2.88 earnings per share for the current fiscal year.

The firm also recently announced a quarterly dividend, which was paid on Wednesday, September 14th. Stockholders of record on Friday, August 26th were paid a dividend of $0.355 per share. This represents a $1.42 annualized dividend and a dividend yield of 2.28%. The ex-dividend date of this dividend was Wednesday, August 24th. Nu Skin Enterprises’s dividend payout ratio (DPR) is currently 81.14%.

Several institutional investors have recently added to or reduced their stakes in the stock. GSA Capital Partners LLP boosted its position in Nu Skin Enterprises by 234.4% in the second quarter. GSA Capital Partners LLP now owns 72,436 shares of the company’s stock valued at $3,346,000 after buying an additional 50,774 shares during the period. Zebra Capital Management LLC acquired a new position in Nu Skin Enterprises during the first quarter valued at approximately $519,000. OMERS ADMINISTRATION Corp purchased a new position in shares of Nu Skin Enterprises during the first quarter valued at about $2,073,000. Spark Investment Management LLC purchased a new position in shares of Nu Skin Enterprises during the first quarter valued at about $2,092,000. Finally, Menta Capital LLC boosted its position in shares of Nu Skin Enterprises by 139.7% in the first quarter. Menta Capital LLC now owns 18,100 shares of the company’s stock valued at $692,000 after buying an additional 10,550 shares during the period. Institutional investors own 77.08% of the company’s stock.

About Nu Skin Enterprises

Nu Skin Enterprises, Inc is a direct selling company that develops and distributes personal care products and nutritional supplements, and a range of other products and services. The Company offers anti-aging personal care products and nutritional supplements under its Nu Skin and Pharmanex brands. The Nu Skin brand offers a range of products, including ageLOC Spa systems, ageLOC Transformation anti-aging skin care system and ageLOC Tru Face Essence Ultra anti-aging skin care serum.

5 Day Chart for NYSE:NUS

Receive News & Ratings for Nu Skin Enterprises Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.